JP2023535026A - ステープルペプチドおよびその方法 - Google Patents

ステープルペプチドおよびその方法 Download PDF

Info

Publication number
JP2023535026A
JP2023535026A JP2023504288A JP2023504288A JP2023535026A JP 2023535026 A JP2023535026 A JP 2023535026A JP 2023504288 A JP2023504288 A JP 2023504288A JP 2023504288 A JP2023504288 A JP 2023504288A JP 2023535026 A JP2023535026 A JP 2023535026A
Authority
JP
Japan
Prior art keywords
independently
group
agent
optionally substituted
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023504288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535026A5 (cg-RX-API-DMAC10.html
Inventor
ブライアン ハルバート ホワイト,
ヤグアン シー,
マーティン ロバート トレンブレイ,
デボラ ゲイル コンラディ,
ユエ-メイ ジャン,
イヴァン タッカー ジュウェット,
ロレンツォ ジョズエ アルファロ-ロペス,
サラ イザベル カプッチ,
ジー リー,
ジョン ハニー マギー,
Original Assignee
フォグ ファーマシューティカルズ, インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フォグ ファーマシューティカルズ, インコーポレイテッド filed Critical フォグ ファーマシューティカルズ, インコーポレイテッド
Publication of JP2023535026A publication Critical patent/JP2023535026A/ja
Publication of JP2023535026A5 publication Critical patent/JP2023535026A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023504288A 2020-07-22 2021-07-22 ステープルペプチドおよびその方法 Pending JP2023535026A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063055308P 2020-07-22 2020-07-22
US63/055,308 2020-07-22
US202163208494P 2021-06-08 2021-06-08
US63/208,494 2021-06-08
PCT/US2021/042856 WO2022020652A2 (en) 2020-07-22 2021-07-22 Stapled peptides and methods thereof

Publications (2)

Publication Number Publication Date
JP2023535026A true JP2023535026A (ja) 2023-08-15
JP2023535026A5 JP2023535026A5 (cg-RX-API-DMAC10.html) 2024-08-08

Family

ID=79728982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023504288A Pending JP2023535026A (ja) 2020-07-22 2021-07-22 ステープルペプチドおよびその方法

Country Status (10)

Country Link
US (1) US20240116985A1 (cg-RX-API-DMAC10.html)
EP (1) EP4185599A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023535026A (cg-RX-API-DMAC10.html)
KR (1) KR20230057350A (cg-RX-API-DMAC10.html)
CN (1) CN116323638A (cg-RX-API-DMAC10.html)
AU (1) AU2021314310A1 (cg-RX-API-DMAC10.html)
CA (1) CA3186681A1 (cg-RX-API-DMAC10.html)
IL (1) IL299907A (cg-RX-API-DMAC10.html)
MX (1) MX2023000947A (cg-RX-API-DMAC10.html)
WO (1) WO2022020652A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004555A2 (pt) 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
AU2019326423A1 (en) 2018-08-20 2021-04-08 Fog Pharmaceuticals, Inc. Collections of peptides, peptide agents, and methods of use thereof
BR112023025528A2 (pt) * 2021-06-08 2024-02-27 Fog Pharmaceuticals Inc Peptídeos grampeados e métodos destes
CN115260060A (zh) * 2022-09-07 2022-11-01 康化(上海)新药研发有限公司 (2s)-2-n-芴甲氧羰基氨基-5,5-二甲基正亮氨酸的合成方法
WO2024054892A1 (en) * 2022-09-09 2024-03-14 Shape Therapeutics Inc. Therapeutic peptides
US20260207704A1 (en) * 2022-12-15 2026-07-23 Parabilis Medicines, Inc. Stapled peptides and methods thereof
WO2024130217A1 (en) * 2022-12-15 2024-06-20 Fog Pharmaceuticals, Inc. Stapled peptides and methods thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040459A2 (en) * 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
WO2019051327A2 (en) * 2017-09-07 2019-03-14 Fog Pharmaceuticals, Inc. BETA CATENIN FUNCTIONALIZATION AGENTS AND ASSOCIATED METHODS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5671196A (en) * 1996-03-28 1997-10-17 Immulogic Pharmaceutical Corporation Myelin oligodendrocyte glycoprotein peptides and uses thereof
US20040181830A1 (en) * 2001-05-07 2004-09-16 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US20050187147A1 (en) * 2003-09-22 2005-08-25 Newman Michael J. Compositions and methods for increasing drug efficiency
WO2009106073A2 (en) * 2008-02-28 2009-09-03 Dako Denmark A/S Mhc multimers in borrelia diagnostics and disease
KR101706789B1 (ko) * 2008-07-21 2017-02-14 프로비오드룩 아게 진단용 항체 검사법
WO2010037395A2 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
WO2014026033A1 (en) * 2012-08-08 2014-02-13 University Of Florida Research Foundation, Inc. Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
GB2563875B (en) * 2017-06-28 2020-08-19 Sutura Therapeutics Ltd Improvements in drug delivery
EP3765852A1 (en) * 2018-03-14 2021-01-20 Dana Farber Cancer Institute, Inc. Stabilized peptides for biomarker detection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012040459A2 (en) * 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
WO2019051327A2 (en) * 2017-09-07 2019-03-14 Fog Pharmaceuticals, Inc. BETA CATENIN FUNCTIONALIZATION AGENTS AND ASSOCIATED METHODS

Also Published As

Publication number Publication date
WO2022020652A2 (en) 2022-01-27
WO2022020652A3 (en) 2022-03-03
KR20230057350A (ko) 2023-04-28
CA3186681A1 (en) 2022-01-27
AU2021314310A1 (en) 2023-03-16
US20240116985A1 (en) 2024-04-11
MX2023000947A (es) 2023-02-22
EP4185599A4 (en) 2024-08-28
EP4185599A2 (en) 2023-05-31
CN116323638A (zh) 2023-06-23
IL299907A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
JP2024522368A (ja) ステープルペプチドおよびその方法
KR20230057350A (ko) 스테이플화된 펩티드 및 이의 방법
JP2025041652A (ja) オリゴヌクレオチド組成物及びその方法
KR20220103986A (ko) 지정 접합 기술
JP2023546369A (ja) N-アセチルガラクトサミン(GalNAc)から誘導された化合物およびオリゴヌクレオチド
WO2015117083A1 (en) Diazepane derivatives and uses thereof
JP7863914B2 (ja) 多環式系化合物およびその使用
WO2019023651A2 (en) MODULATORS OF THE SMALL MOLECULE ANDROGEN RECEPTOR
WO2019168654A9 (en) Dna-templated macrocycle library
CN116113621A (zh) 氨基酸
JP2025541246A (ja) ステープルペプチドおよびその方法
JP2025541247A (ja) ステープルペプチドおよびその方法
WO2009132032A2 (en) Sonic hedgehog modulators
WO2023114539A1 (en) Amino chromen-2-one modulators of polrmt
WO2023034340A1 (en) Hydroxy and alkoxy coumarins as modulators of polrmt
HK40108355A (en) Stapled peptides and methods thereof
CN113045567A (zh) 基于蛋白磷酸酶5的磷酸酶募集嵌合体(PHORCs)化合物、其制备方法和医药用途
HK40129655A (zh) 订书钉化肽及其方法
CN117794560A (zh) 订书钉化肽及其方法
HK40128981A (zh) 订书钉化肽及其方法
WO2025265097A1 (en) Stapled peptides and methods thereof
KR20260035134A (ko) 스테이플화 펩티드 및 이의 방법
US20240391956A1 (en) Stapled peptides and methods thereof
US20250353816A1 (en) Quinolines as modulators of polrmt
EP4644374A1 (en) Naphthylamide compound, and preparation method therefor and use thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240722

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240731

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250926

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260701